15 hrs ago
FDA Approves Mercka s NOXAFIL (posaconazole) Injection (18 mg/mL) for Intravenous Use
Merck's antifungal agent is also marketed as NOXAFIL delayed-release tablets and NOXAFIL oral suspension.
Trending on the Topix Network
Thu Mar 13, 2014
Paytronix Proves SMBs Can Do Big Data Analysis
Running a Cloudera Hadoop cluster on Amazon Web Services, Paytronix gains insight into customer behavior it couldn't tease out of a database.
Bionomics Wins Awards at Major BioPharma Asia Convention
The citation underpinning the Innovative Asian Biotech of the Year award made reference to Bionomics' ability to adopt innovative technologies to develop novel drugs.
Wed Mar 12, 2014
Investors Buy High Volume of Merck & Co. Put Options
Merck & Co. was the recipient of some unusual options trading on Wednesday. Investors bought 8,671 put options on the stock, AnalystRatings.NET reports.
U.S. cattle deaths linked to Zilmax far exceed com...
The number of U.S. cattle deaths that may be linked to the Merck & Co Inc feed additive Zilmax are much higher than the figures reported by the drug company to the federal government, according to a research study published on Wednesday.
Merck shares are unchanged at $56.69 in Wednesday's trading. After breaching Tuesday's low off the open, reaching $56.26, the issue has rebounded to $56.93.
Sun Mar 09, 2014
Malaysian National News Agency
Merck's Consumer Health Division Breaks $1bn Barrier
KUALA LUMPUR, March 7 -- Merck's Consumer Health division has reported an increase in annual sales of Consumer Health by approximately 55 percent to over $1 billion .
New Market Research Report: Primary Dysmenorrhea - Pipeline Review, H1 2014
This report provides information on the therapeutic development for Primary Dysmenorrhea, complete with latest updates, and special features on late-stage and discontinued projects.
Fri Mar 07, 2014
Biotech Bust: 5 Drivers
What the heck happened to the biotechnology sector on Thursday ? It's continuing on Friday, with Gilead Sciences and iShares Nasdaq Biotechnology Index ETF down by 2% and 1.3%, respectively.
Stocks with implied volatility movement; Gild Celg
Gilead weakness a buying opportunity, says Stifel Stifel sees the weakness in Gilead which was caused by Merck's announcement of a competitive drug, as a buying opportunity.
Thu Mar 06, 2014
Alnylam closes $175M purchase of Merck subsidiary
Alnylam Pharmaceuticals has closed its $175 million acquisition of Sirna Therapeutics Inc., a subsidiary of Merck & Co., it said Thursday.
View Press Release
Move reinforces business strategy to reach a minimum of 3% total share per key market and at least 3 leading brands in investment markets )--Merck's Consumer Health division has significantly increased in size following its incorporation of NeurobionA , a leading global brand in the vitamin B segment, and FloratilA , a leading brand in Brazil in ... (more)
Wed Mar 05, 2014
Merck's Investigational HIV Therapy, Doravirine (MK-1439),...
Merck , known as MSD outside the United States and Canada, today presented data from the dose-ranging portion of an ongoing Phase 2B clinical trial of doravirine, the company's investigational next-generation, non-nucleoside reverse transcriptase inhibitor , at the 21st Conference on Retroviruses and Opportunistic Infections .
Merck & Co., Inc.'s Dust Mite Allergy Drug Reduces Symptoms In Phase 2b Study
Merck Announces Results from Phase 2b Study of MK-8237, an Investigational House Dust Mite Sublingual Allergen Immunotherapy Tablet WHITEHOUSE STATION, N.J.-- -- Merck , known as MSD outside the United States and Canada, today announced results from a Phase 2b study evaluating two doses of its investigational house dust mite sublingual ... (more)
Tue Mar 04, 2014
Press release distribution, EDGAR filing, XBRL, regulatory filings
Kindred's dedicatio... )--Getty Realty Corp. announced its financial results for the quarter and year ended December 31, 2013.
Collaborating online for the next breakthrough in life sciences
Sales and traffic to online retailers by category and merchant type, data on Amazon and other leading e-retailers, comparisons of leading web retailers, site performance data, more.
Mon Mar 03, 2014
GuruFocus Names Five Dividend Growers
During the past week, GuruFocus recognized five companies as dividend growers. In order to be qualified for this list, the company had to: The following five companies come from various industries and sectors of the market, but they all fit the necessary criteria needed to qualify them as dividend growers.
Portola Pharmaceuticals Inc - 10-K - Management's Discussion and...
You should read the following discussion and analysis of our financial condition and results of operations together with the section of this report entitled "Selected financial data" and our financial statements and related notes included elsewhere in this report.
Sat Mar 01, 2014
The Motley Fool
The 4 Surprising Stocks Leading the Dow Jones Industrials So Far in 2014
After five years of gains in one of the most powerful bull markets in recent memory, the Dow Jones Industrials have gotten off to a slow start in 2014.
Fri Feb 28, 2014
MERCK & CO. INC. FILES (8-K) Disclosing Amendments to Articles of...
MERCK & CO. INC. FILES Disclosing Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits amended Article I, Section 2 of the By-Laws of the Company to provide that special meetings of shareholders may be called by shareholders owning at least fifteen percent of the combined voting power of the then ... (more)